adenosine
UkraineDrugs containing this active substance
-
The drug is used as part of complex therapy for acute and chronic hepatitis, liver cirrhosis, fatty dystrophy (steatosis), alcoholic liver disease, as well as for intoxication due to long-term intake of antineoplastic or anti-tuberculosis drugs.
Form: powder for injection solution
Active substance Dosage orotic acid carnitine 300.0 mg levocarnitine hydrochloride 184.0 mg antitoxic fraction of liver extract 25.0 mg adenosine 5.0 mg pyridoxine hydrochloride 25.0 mg cyanocobalamin 0.25 mg ATC: A16AA
Manufacturer: Farmeks Group LLC (manufacturing, packaging, quality control)
-
The drug is intended to arrest the development of cataracts. It can also be used for prevention, as well as for non-infectious inflammatory processes of the anterior segment of the eye.
Form: drops, ophthalmic solution
Active substance Dosage cytochrome c 0.675 mg/ml adenosine 2 mg/ml nicotinamide 20 mg/ml ATC: S01XA
Manufacturer: LLC "FARMEKS GROUP"
-
The drug is intended to delay the development of cataracts. It can also be used for prophylactic purposes.
Form: drops, ophthalmic
Active substance Dosage cytochrome c 0.675 mg/ml adenosine 2 mg/ml nicotinamide 20 mg/ml ATC: S01XA
Manufacturer: Santen AG (manufacturer responsible for batch release)